Major League Baseball has announced that Braves outfielder Jurickson Profar has been suspended for 80 games after testing positive for a performance-enhancing drug. Reporter Mike Rodriguez first relayed that Profar was to get a suspension due to a positive test. Jeff Passan of ESPN confirmed that it would be a PED suspension. Profar will be able to return during the season but won’t be eligible for the playoffs this year, as is true for all players in the year they serve a PED suspension.
MLB announced the suspension with the following statement: “The Office of the Commissioner of Baseball announced today that Atlanta Braves outfielder Jurickson Profar has received an 80-game suspension without pay after testing positive for Chorionic Gonadotrophin (hCG), a performance enhancing substance, in violation of Major League Baseball’s Joint Drug Prevention and Treatment Program. The suspension of Profar is effective immediately.”
The team also released a statement: “We were surprised and extremely disappointed to learn that Jurickson Profar tested positive for a performance-enhancing substance in violation of Major League Baseball’s Joint Prevention and Treatment Program. We fully support the Program and are hopeful that Jurickson will learn from this experience.”
Profar himself also released a statement through the MLBPA: “Braves fans, Today is the most difficult day of my baseball career. I am devastated to announce that I have been suspended for 80 games by Major League Baseball and the Commissioner’s office, for testing positive for a banned substance this offseason. This is especially painful for me because anyone who knows me and has seen me play knows I am deeply passionate about the game. There is nothing I love more than competing with my teammates and being a fan favorite. I want to apologize to the entire Braves organization, my teammates, and the fans. It is because of my deep love and respect for this game that I would never knowingly do anything to cheat it. I have been tested my entire career, including eight times last season alone, and have never tested positive. I would never willingly take a banned substance, but I take full responsibility and accept MLB’s decision. I am devastated that I won’t be on the field with my teammates for the next 80 games. I look forward to competing again at the highest level this season upon my return.”
The news will immediately cast a new light on Profar’s breakout campaign in 2024. A former top prospect, his big league career had been fairly inconsistent. His plate discipline had always been good, with above average strikeout and walk rates throughout most of his career, but generally with a lack of impact. At the end of the 2023 season, he had appeared in 961 big league games and was sitting on a .238/.322/.383 battling line. That production translated to a 92 wRC+, indicating he had been 8% worse than league average overall.
His stock had fallen far enough that he settled for a $1MM deal with the Padres going into 2024, barely above last year’s $740K league minimum salary. He went on to have the best season of his career at the age of 31. He hit 24 home runs for the Friars while drawing walks at an 11.4% clip and striking out just 15.1% of the time. His .280/.380 /.459 batting line translated to a 139 wRC+, easily the best of his career. Relative to 2023, his average exit velocity jumped from 86.5 miles per hour to 91.1. His hard hit rate went from 31.8% to 44.4%. In general, just about everything on his Statcast page got redder.
That made him a much hotter commodity this past offseason. He got interest from clubs like the Mets, Royals, Blue Jays and Astros before signing a three-year, $42MM deal with Atlanta in January. This news will naturally lead the baseball world to re-evaluate that breakout season.
Presumably, Atlanta had no idea about Profar’s test when they signed him or they wouldn’t have done the deal. Still, it will be a massive headache for them and looks like a big waste of resources. The club took a very measured approach this winter, seemingly working under specific financial restraints. They flipped Jorge Soler and the remainder of his contract to the Angels as soon as the offseason began. They later turned down a reasonable club option on Travis d’Arnaud. They renegotiated the contracts of Reynaldo López and Aaron Bummer, in both cases kicking a bit of money from 2025 to 2026.
In hindsight, it seems the club was trying to get the payroll down to a specific level and get themselves under the competitive balance tax. Per RosterResource, their CBT number is currently around $234MM. That’s about $7MM shy of this year’s $241MM base threshold, leaving them a bit of wiggle room to make in-season moves and reset their tax status this year. Assuming they indeed follow through on that, they could go into 2026 as “first-time” payors, after paying the tax in 2023 and 2024.
Around the frugal moves, Profar was their one big splash. They didn’t give out another deal worth more than $1.5MM. The outfield was an obvious target area. Last year’s acquisition of Jarred Kelenic didn’t work out, as he hit .231/.286/.393 in his first season in Atlanta. Ronald Acuña Jr. tore his left ACL in May and missed the remainder of the season. They made midseason acquisitions of Soler and Ramón Laureano but both were dispatched this winter for financial reasons. Soler was flipped to the Angels for Griffin Canning, with Canning later non-tendered. Laureano, who was projected for a $6.1MM salary, was himself non-tendered.
Considering all of that, it’s obviously a less than ideal development. The club tried to walk a fine line all winter, pinching pennies while hopefully keeping themselves in position to compete in 2025. Amid several subtractions, Profar was their most aggressive addition. Now he’s going to be out of action for a long while and it’s anyone’s guess what form he will be in when he comes back. He won’t be eligible for postseason play this year regardless.
He won’t be paid while serving his suspension, saving the club a bit of money, but they have few options for redirecting those funds now that the season has started. The team will now have to improvise a way to proceed. Harris is still a strong option in center but the corner options aren’t incredibly inspiring. Kelenic figures to get plenty of playing time, though as mentioned, he struggled last year and has a .154/.154/.385 line so far this year. Bryan De La Cruz and Eli White are also on the active roster. Stuart Fairchild was claimed off waivers today and will join the club shortly. Carlos Rodriguez is on the 40-man but on optional assignment.
In time, that picture should improve. Alex Verdugo was signed just over a week ago. He agreed to be optioned for now so that he could ramp up after missing spring training and should join the club in the coming weeks. Acuña could potentially be reinstated off the injured list in May. Profar will eventually return from this suspension but won’t be postseason eligible. Players on other clubs could become available as the trade deadline nears.
Nonetheless, it’s a gut check for a club that is already reeling a bit. They lost their first four games, getting swept by Profar’s old club in San Diego. There’s still a long season ahead, but they were set for a tough battle in a packed NL East. As mentioned, they tried to walk a tightrope this winter by cutting spending but still competing. Profar was the jewel of that offseason but the shine has come off real fast.
Photo courtesy of Mike Lang, Imagn Images.
